A sex paradox in clinical outcomes following complex percutaneous intervention. Treatment bias, biology or both?

Affiliations

¹ Department of Cardiology, Universitat Autònoma, Barcelona, Spain; Research Institute, Hospital Universitari Vall d'Hebron, Universitat Autònoma, Spain; CIBER-CardioVascular diseases (CIBER-CV), Barcelona, Spain. Electronic address: asambola@vhebron.net.
² Department of Cardiology, Universitat Autònoma, Barcelona, Spain; Research Institute, Hospital Universitari Vall d'Hebron, Universitat Autònoma, Spain; CIBER-CardioVascular diseases (CIBER-CV), Barcelona, Spain.

Editorial

Antonia Sambola et al. Int J Cardiol. 2021.

. 2021 Apr 15:329:77-78.

doi: 10.1016/j.ijcard.2020.12.072. Epub 2020 Dec 31.

¹ Department of Cardiology, Universitat Autònoma, Barcelona, Spain; Research Institute, Hospital Universitari Vall d'Hebron, Universitat Autònoma, Spain; CIBER-CardioVascular diseases (CIBER-CV), Barcelona, Spain. Electronic address: asambola@vhebron.net.
² Department of Cardiology, Universitat Autònoma, Barcelona, Spain; Research Institute, Hospital Universitari Vall d'Hebron, Universitat Autònoma, Spain; CIBER-CardioVascular diseases (CIBER-CV), Barcelona, Spain.

No abstract available

Comment on

A sex paradox in clinical outcomes following complex percutaneous coronary intervention.
Nicolas J, Claessen BE, Cao D, Chiarito M, Sartori S, Qiu H, Goel R, Nardin M, Roumeliotis A, Vogel B, Turfah A, Chandiramani R, Baber U, Barman N, Sweeny J, Krishnan P, Kini A, Sharma SK, Dangas GD, Mehran R. Nicolas J, et al. Int J Cardiol. 2021 Apr 15;329:67-73. doi: 10.1016/j.ijcard.2020.11.067. Epub 2020 Dec 2. Int J Cardiol. 2021. PMID: 33278415